Catalyst Pharmaceuticals Announces Proposed Settlement Of Pending Securities Class Action Lawsuit

By: via Benzinga
Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) (Catalyst Pharmaceuticals or the Company), a biopharmaceutical company focused on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.